GAMMA Investing LLC boosted its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 1,389.0% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 432,826 shares of the pharmacy operator's stock after acquiring an additional 403,757 shares during the quarter. GAMMA Investing LLC owned approximately 0.05% of Walgreens Boots Alliance worth $4,835,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $26,000. Riverview Trust Co boosted its position in Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after buying an additional 1,590 shares during the last quarter. Colonial Trust Co SC increased its stake in shares of Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock valued at $27,000 after buying an additional 1,297 shares during the period. Venturi Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at $28,000. Finally, Central Pacific Bank Trust Division raised its position in shares of Walgreens Boots Alliance by 28.6% during the first quarter. Central Pacific Bank Trust Division now owns 4,500 shares of the pharmacy operator's stock worth $50,000 after acquiring an additional 1,000 shares during the last quarter. Institutional investors own 58.59% of the company's stock.
Wall Street Analyst Weigh In
WBA has been the topic of several recent research reports. Wall Street Zen started coverage on Walgreens Boots Alliance in a report on Wednesday, May 21st. They issued a "hold" rating on the stock. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and lowered their price target for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. Finally, Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, Walgreens Boots Alliance has an average rating of "Hold" and a consensus price target of $10.59.
Check Out Our Latest Report on WBA
Walgreens Boots Alliance Trading Up 0.3%
Shares of WBA stock traded up $0.03 on Friday, hitting $11.39. The stock had a trading volume of 6,884,149 shares, compared to its average volume of 20,796,120. The company has a fifty day moving average price of $11.08 and a two-hundred day moving average price of $10.65. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The firm has a market cap of $9.85 billion, a P/E ratio of -1.11, a PEG ratio of 1.31 and a beta of 0.78. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $16.25.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. During the same quarter in the previous year, the business posted $1.20 EPS. Walgreens Boots Alliance's revenue for the quarter was up 4.1% on a year-over-year basis. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, Chairman Stefano Pessina acquired 832,258 shares of the company's stock in a transaction dated Sunday, April 27th. The shares were bought at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the purchase, the chairman now directly owns 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. This trade represents a 0.57% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 17.50% of the company's stock.
Walgreens Boots Alliance Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
See Also
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
